KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Depreciation and Depletion (2016 - 2025)

Opko Health (OPK) has disclosed Depreciation and Depletion for 11 consecutive years, with $3.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation and Depletion fell 10.81% year-over-year to $3.3 million, compared with a TTM value of $13.7 million through Dec 2025, down 12.18%, and an annual FY2025 reading of $13.7 million, down 12.18% over the prior year.
  • Depreciation and Depletion was $3.3 million for Q4 2025 at Opko Health, up from $3.2 million in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $8.0 million in Q2 2021 and bottomed at $3.2 million in Q3 2025.
  • Average Depreciation and Depletion over 5 years is $4.9 million, with a median of $4.8 million recorded in 2022.
  • The sharpest move saw Depreciation and Depletion increased 9.59% in 2021, then crashed 35.0% in 2022.
  • Year by year, Depreciation and Depletion stood at $6.6 million in 2021, then fell by 25.76% to $4.9 million in 2022, then decreased by 8.16% to $4.5 million in 2023, then dropped by 17.78% to $3.7 million in 2024, then decreased by 10.81% to $3.3 million in 2025.
  • Business Quant data shows Depreciation and Depletion for OPK at $3.3 million in Q4 2025, $3.2 million in Q3 2025, and $3.6 million in Q2 2025.